Diagnostics & Tech

The acquisition of Texas-based KAI Medical Laboratory establishes the science and research side of Empower.

Kai Laboratory

Our lab offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology through its hospitals, medical clinics and pharmacies.

Our High Complexity CLIA and COLA accredited lab is active in COVID-19 testing, RT-PCR testing and serology testing with the capacity to process 4,000 RT-PCR test specimens per day.

COVID-19 Testing

In 2020, Empower re-purposed its pre-existing diagnostic testing to serve the massive demand for national COVID testing in the US.
In partnership with Loop Insights Inc., Empower provides a safe and viable economic recovery solution for American companies. Together, we have created a system built on the pillars of:
  • Venue tracing
  • Frequent testing with rapid results
  • Real-time reporting to ensure the travel bubble provides end-to-end protection


KAI Medical Laboratory through its scientists and researchers is developing novel diagnostic and test protocols to address the combination of COVID-19, Influenza A and Influenza B.
The KAI Medical ABC PCR test launched Q4 2020.

KAI Medical completed clinical trials, laboratory analysis and validation of the API Pharma Rapid COVID-19 Antigen test submitted to the FDA for approval for use in the US and has submitted a Health Canada application.

The tests are developed with the highest of standards and meet CDC, Health Canada and FDA guidelines for distribution and sale.

Demand for this novel test is high and will be sold through partners serving the public sector and the medical community throughout North America.

Kai Medical has developed a Saliva PCR test for at home specimen collection to detect COVID-19 and Influenza A/B with end user comfort in mind.


COVID-19 is currently limiting hospital resources, and social distancing and stay-at-home orders detering patients from venturing out to make routine, in-person visits with physicians – leading to rapid adoption of virtual medicine.
The Center for Disease Control and Prevention (CDC) recommends leveraging telehealth to help mitigate the impact and spread of COVID-19. Telemedicine services are helping to provide necessary care to patients while minimizing the transmission risk of COVID-19, to healthcare workers and patients.

Even once we reach a post-COVID-19 world, we strongly believe that telemedicine is the future of delivery of healthcare. Currently, about 59 million Americans reside in health professional-shortage areas, which are rural and urban areas with shortages of primary care providers. Telemedicine allows patients living in both rural and urban areas to access healthcare when they need it. It also has been used successfully to improve patient access to medical care while reducing healthcare costs.

Empower currently provides its telemedicine platform to patients in Washington State, Oregon, and Arizona, however, we plan to roll out a nationwide telemedicine platform to provide continuity of care for patients who cannot physically make the trip to our clinics.